Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. CytoDyn Inc (CYDY) Message Board

Important: Public Citizen\'s Health Research Group

Message Board Public Reply | Private Reply | Keep | Replies (1)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 154646
(Total Views: 1181)
Posted On: 05/08/2021 3:38:57 PM
Posted By: melsdollars
Hi All
I ran across this Request from Public Citizen's Heath Research Group to the FDA and CDER demanding a reconsideration of the FDA's approval of Remdesivir. Click on the PDF to see the full document, not just the press release.

https://www.citizen.org/article/letter-to-the...-covid-19/

PDF: https://mkus3lurbh3lbztg254fzode-wpengine.net...s/2578.pdf

I have not heard of this group before, but according to Public Citizen, the FDA did not follow their own guidelines and consult with the Drugs Advisory Committee prior to approval and ignored conflicting data and safety issues from other trials. If you read the attached PDF, you can see that this document goes into great detail about how the Remdesivir data was "sliced and diced" and ultimately a small subgroup was the basis for FDA approval. That in itself was very interesting, because the hedge fund naysayers have been saying for months that the FDA doesn't issue EUA's or approvals based on sub groups or cherry picked data, but that wasn't the part that intrigued me. The part that I found most interesting was the fact that the authors of this document, the research group, obviously have a deep understanding of clinical trials and approvals, and are not afraid to challenge the status quo. Their names and emails can be found at the end of the document.

Unfortunately, I'm traveling and don't have the time to fully explore and act on this, but thought I'd post it here and see if anyone else has relevant contacts, thoughts or ideas.

A few questions came to mind:

Do Senator Sanders and Rand know of this report on Remdesivir?

Has this group heard of Leronlimab? What is the most concise way to get the story of Leronlimab across to this group?

Do they know about our failure to secure an EUA despite our top notch safety record, NEWS2 scores and incredibly promising results in the critical patients?

Do Drs. Lalezari and Seethamraju know about this group and would they be interested in reaching out to them for assistance?

Thanks so much.





(18)
(0)




CytoDyn Inc (CYDY) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us